tiprankstipranks
Advertisement
Advertisement
FDA posts approval of Edwards left atrial appendage system
PremiumThe FlyFDA posts approval of Edwards left atrial appendage system
26d ago
AI Models Turn More Positive on AtriCure as Fundamentals Strengthen
Premium
AI Analyst Ratings
AI Models Turn More Positive on AtriCure as Fundamentals Strengthen
28d ago
AtriCure management to meet with Piper Sandler
Premium
The Fly
AtriCure management to meet with Piper Sandler
1M ago
AtriCure Earnings Call Highlights Profitable Growth Pivot
PremiumCompany AnnouncementsAtriCure Earnings Call Highlights Profitable Growth Pivot
3M ago
AtriCure reports Q1 EPS ,0c consensus (6c)
Premium
The Fly
AtriCure reports Q1 EPS ,0c consensus (6c)
3M ago
Is ATRC a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATRC a Buy, Before Earnings?
3M ago
AtriCure price target lowered to $55 from $60 at UBS
PremiumThe FlyAtriCure price target lowered to $55 from $60 at UBS
5M ago
AtriCure price target lowered to $53 from $64 at Canaccord
Premium
The Fly
AtriCure price target lowered to $53 from $64 at Canaccord
5M ago
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
Premium
Ratings
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100